ContextVision presents Q2 report

Q2 HIGHLIGHTS

  • Further positive sales development

  • New major long term ultrasound customer signed

  • All cases in long lasting legal dispute finally closed

Q2 FINANCIAL DATA

  • Sales of 15.8 MSEK (14.0)

  • Operating result of 2.6 MSEK (-1.9) and operating margin of 16.6% (-13.3%).

  • Earnings per share of 0,28 (-0,18) SEK

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit www.contextvision.com.

Subscribe

Documents & Links